1. Home
  2. BFRG vs PTHL Comparison

BFRG vs PTHL Comparison

Compare BFRG & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFRG
  • PTHL
  • Stock Information
  • Founded
  • BFRG 2017
  • PTHL 1998
  • Country
  • BFRG United States
  • PTHL China
  • Employees
  • BFRG N/A
  • PTHL N/A
  • Industry
  • BFRG Retail: Computer Software & Peripheral Equipment
  • PTHL
  • Sector
  • BFRG Technology
  • PTHL
  • Exchange
  • BFRG Nasdaq
  • PTHL Nasdaq
  • Market Cap
  • BFRG 10.4M
  • PTHL 8.8M
  • IPO Year
  • BFRG 2023
  • PTHL 2024
  • Fundamental
  • Price
  • BFRG $0.87
  • PTHL $0.56
  • Analyst Decision
  • BFRG
  • PTHL
  • Analyst Count
  • BFRG 0
  • PTHL 0
  • Target Price
  • BFRG N/A
  • PTHL N/A
  • AVG Volume (30 Days)
  • BFRG 152.5K
  • PTHL 122.1K
  • Earning Date
  • BFRG 11-14-2025
  • PTHL 01-01-0001
  • Dividend Yield
  • BFRG N/A
  • PTHL N/A
  • EPS Growth
  • BFRG N/A
  • PTHL N/A
  • EPS
  • BFRG N/A
  • PTHL N/A
  • Revenue
  • BFRG $116,670.00
  • PTHL $448,196.00
  • Revenue This Year
  • BFRG N/A
  • PTHL N/A
  • Revenue Next Year
  • BFRG N/A
  • PTHL N/A
  • P/E Ratio
  • BFRG N/A
  • PTHL N/A
  • Revenue Growth
  • BFRG N/A
  • PTHL N/A
  • 52 Week Low
  • BFRG $0.80
  • PTHL $0.47
  • 52 Week High
  • BFRG $4.84
  • PTHL $32.00
  • Technical
  • Relative Strength Index (RSI)
  • BFRG 31.28
  • PTHL 38.37
  • Support Level
  • BFRG $0.80
  • PTHL $0.54
  • Resistance Level
  • BFRG $0.99
  • PTHL $0.66
  • Average True Range (ATR)
  • BFRG 0.09
  • PTHL 0.06
  • MACD
  • BFRG -0.01
  • PTHL 0.02
  • Stochastic Oscillator
  • BFRG 22.93
  • PTHL 52.13

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Share on Social Networks: